Cuprina Holdings (Cayman) Ltd. (CUPR) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.84

From 52W high−77.65%

Volume7514.00

Market cap$13.17M

P/E (TTM)—

P/S (TTM)337.8x

Div yield—

Key dataOct 19, 2026

Open

$1.84

From 52W high

−77.65%

Volume

7514.00

Market cap

$13.17M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.1x

P/E (TTM)

—

RSI (14)

41.3

MomentumView details →

1D Return

−1.05%

YTD Return

−42.50%

SummaryUpdated Dec 1, 2025

Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) is a Singapore-based biomedical and biotechnology company that went public in April 2025. Founded as a specialized developer of innovative wound care solutions, the company has positioned itself at the intersection of biotechnology and medical device manufacturing. Cuprina operates primarily in the chronic wound management sector, developing and commercializing biological products for healthcare applications, while also maintaining a presence in the cosmeceutical market.

Ask drillr about Cuprina Holdings (Cayman) Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.1x

EV/Sales

285.0x

P/S (TTM)

337.8x

P/B (TTM)

3.3x

ProfitabilityView details →

Gross Margin

−1.29%

Net Margin

−9366.75%

EBITDA Margin

−9137.07%

ROE (TTM)

−92.44%

ROA (TTM)

−54.95%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−4.12%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−1.05%

YTD Return

−42.50%

1Y Return

−75.53%

RSI (14)

41.3

vs 50D SMA

−26.34%

vs 200D SMA

−40.66%

Capital & dividendView details →

Debt/Equity

0.10x

Current Ratio

2.35x

Quick Ratio

2.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Cuprina Holdings (Cayman) Limited closed a public offering of 4,322,489 Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds.32d ago

Similar companies

Tvardi Therapeutics, Inc.TVRD Vyome Holdings, Inc.HIND Lipocine Inc.LPCN BioCardia, Inc.BCDA Pasithea Therapeutics Corp.KTTA Daré Bioscience, Inc.DARE Find similar companies →

Latest newsMore news →

Cuprina Holdings (Cayman) Limited, through its subsidiary Cuprina Holdings (BVI) Limited, entered into Sale and Purchase Agreements to acquire the entire issued share capital of East Coast Podiatry Centre Pte. Ltd. and Orchard Clinic Management Pte. Ltd. in Singapore.17d ago Cuprina Holdings (Cayman) Limited closed a public offering of 4,322,489 Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds.32d ago